News & Updates

Type 2 diabetes (T2D) patients who are taking multiple medications together are at heightened risk of bone fractures, a study has found.

Treatment with a higher dose of semaglutide led to significantly improved glucose metabolism outcomes in patients with overweight/obesity and type 2 diabetes (T2D) compared with a lower dose of semaglutide or placebo, according to the STEP* 2 trial presented at EASD 2021.

A total diet replacement programme produces greater weight loss among people with obesity as compared with support from a practice nurse, with the benefit persisting to at least 3 years, a study has found.

Three surrogate measures of insulin resistance are positively associated with incident major depressive disorder among adults with no history of depression or anxiety disorder, results of the Netherlands Study of Depression and Anxiety (NESDA) have shown. Moreover, the development of prediabetes between study enrolment and 2-year visit also predicts incident major depressive disorder.

In a systematic review and meta-analysis, glycaemic parameters in patients with type 1 diabetes (T1D) improved during the COVID-19 lockdown periods. Conversely, patients with type 2 diabetes (T2D) had short-term worsening of glycaemic values.

Among patients with chronic coronary syndromes, those with higher serum uric acid (SUA) levels are more likely to have major adverse cardiovascular (CV) events (MACE) and worse related quality of life (QoL), as reported in a study.

The development of nonalcoholic fatty liver disease (NAFLD) and progression of fibrosis contribute to a higher risk of incident chronic kidney disease (CKD), suggests a recent study.

Both exogenous hyper- and hypothyroidism may increase the risk of incident stroke, according to a study, which notes the importance of patient medication safety.